Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
J. Leighton Read currently holds 34,922 shares of Alexza Pharmaceuticals Inc. (ALXA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. Leighton Read has been a net neutral trader of ALXA stock. They have purchased $0 and sold $0 worth of shares.
J. Leighton Read's most recent insider trade was on Jun 21, 2016, when they sold 3,492 shares at $0.00 per share.
J. Leighton Read serves as Executive at Alexza Pharmaceuticals Inc. (ALXA). They have executed 5 insider transactions totaling $0 over their tenure at the company.
J. Leighton Read holds the position of Executive at Alexza Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
J. Leighton Read has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by J. Leighton Read was on Jun 21, 2016, when they sold $0 worth of ALXA shares. This transaction involved 3,492 shares at N/A per share.
J. Leighton Read currently owns 34,922 shares of Alexza Pharmaceuticals Inc. (ALXA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of J. Leighton Read's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. J. Leighton Read has 5 Form 4 filings on record as an insider at Alexza Pharmaceuticals Inc..
Set alerts for J. Leighton Read and 40,000+ other insiders.